Cargando…
Proteomic Analysis in Morquio A Cells Treated with Immobilized Enzymatic Replacement Therapy on Nanostructured Lipid Systems
Morquio A syndrome, or mucopolysaccharidosis type IVA (MPS IVA), is a lysosomal storage disease due to mutations in the N-acetylgalactosamine-6-sulfatase (GALNS) gene. Systemic skeletal dysplasia and the related clinical features of MPS IVA are due to disruption of cartilage and its extracellular ma...
Autores principales: | Álvarez, J. Víctor, Bravo, Susana B., García-Vence, María, De Castro, María J., Luzardo, Asteria, Colón, Cristóbal, Tomatsu, Shunji, Otero-Espinar, Francisco J., Couce, María L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769449/ https://www.ncbi.nlm.nih.gov/pubmed/31540344 http://dx.doi.org/10.3390/ijms20184610 |
Ejemplares similares
-
Plasma Proteomic Analysis in Morquio A Disease
por: Álvarez, José V., et al.
Publicado: (2021) -
Enzyme-Loaded Gel Core Nanostructured Lipid Carriers to Improve Treatment of Lysosomal Storage Diseases: Formulation and In Vitro Cellular Studies of Elosulfase Alfa-Loaded Systems
por: Álvarez, J. Víctor, et al.
Publicado: (2019) -
Characterization of New Proteomic Biomarker Candidates in Mucopolysaccharidosis Type IVA
por: Álvarez, Víctor J., et al.
Publicado: (2020) -
The Application of Microencapsulation Techniques in the Treatment of Endodontic and Periodontal Disease
por: Álvarez, Asteria Luzardo, et al.
Publicado: (2011) -
Automated Assessment of Thoracic-Abdominal Asynchrony in Patients with Morquio Syndrome
por: Ratnagiri, Madhavi V., et al.
Publicado: (2021)